Researchers at the Institut Pasteur de Tunis have been conducting in-depth studies since 2023 on genetic factors that may explain cognitive decline in some diabetic patients and its potential progression to Alzheimer's disease. This initiative aims to enhance early detection of at-risk populations and optimize their medical care. The research is part of a global effort to better understand the relationship between the two conditions.
Professor Rim Kalfi, a geneticist at the Institut Pasteur, presented findings at a scientific conference organized by the Cité des sciences à Tunis in collaboration with Alzheimer Tunisia. The conference focused on "Alzheimer: Innovation, Prevention, and Support." According to Kalfi, recent studies show that approximately 70% of people with diabetes are at risk of cognitive decline, increasing their likelihood of developing Alzheimer's.
A specialized team at the Institut Pasteur has been working to identify mechanisms that predispose certain diabetics to cognitive decline. The researchers are currently conducting a pilot study involving 100 diabetic patients. The goal is to isolate scientific biomarkers that can map the correlation between the two conditions and anticipate individual vulnerability.
Although the study is ongoing, it is expected to expand to a larger cohort of patients. The final results are anticipated to be completed in the coming years. The research may lead to the development of specific blood tests and genetic tests for diabetics to assess their predisposition to Alzheimer's disease.
The ultimate goal of this research is to enable early detection of Alzheimer's disease in diabetic patients. By identifying those at highest risk, medical professionals can provide closer monitoring and targeted interventions to slow symptom progression. According to experts, this preventive approach is crucial in the absence of major therapeutic breakthroughs in the fight against Alzheimer's.
The study's findings could pave the way for new diagnostic tools, allowing for earlier intervention and potentially improving patient outcomes. The research team's efforts focus on enhancing the understanding of the complex relationship between diabetes and Alzheimer's disease.
The Institut Pasteur de Tunis's research initiative marks a significant step toward addressing the growing concern of Alzheimer's disease in Tunisia. With a large proportion of the population at risk, the development of effective diagnostic and preventive measures is of paramount importance.
Key points
- Researchers at Institut Pasteur de Tunis investigate genetic link between diabetes and Alzheimer's disease.
- 70% of people with diabetes are at risk of cognitive decline, increasing their likelihood of developing Alzheimer's.
- The study aims to develop specific blood tests and genetic tests for diabetics to assess their predisposition to Alzheimer's disease.
